<?xml version="1.0" encoding="ISO-8859-1"?><rss version="2.0"><channel><title>Sorin SpaAz RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehen</description><link>http://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><image><url>http://images.finanzen.net/images/finanzen_net_neu.gif</url><title>Finanzen.net</title><link>http://www.finanzen.net</link></image><item><title>Sorin Group Receives Regulatory Approval to Market Memo 3D(TM) Annuloplasty Ring in Japan</title><link>http://www.finanzen.net/nachricht/Sorin-Group-Receives-Regulatory-Approval-to-Market-Memo-3D-TM-Annuloplasty-Ring-in-Japan-1871038</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwalignc {text-align: center}
.bwlistitemmargb {margin-bottom: 10.0px}
--&gt;
&lt;/style&gt;

			&lt;!-- sh_cad_1 --&gt;
      Sorin Group, (Reuters Code: SORN.MI), a global medical device company 
      and a leader in the treatment  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Sorin-Group-Receives-Regulatory-Approval-to-Market-Memo-3D-TM-Annuloplasty-Ring-in-Japan-1871038</guid></item><item><title>Sorin Group Announces FDA Approval and Commercial Launch of Complete Portfolio of Implantable Heart Device Leads</title><link>http://www.finanzen.net/nachricht/Sorin-Group-Announces-FDA-Approval-and-Commercial-Launch-of-Complete-Portfolio-of-Implantable-Heart-Device-Leads-1856711</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwlistitemmargb {margin-bottom: 10.0px}
--&gt;
&lt;/style&gt;

			
      Sorin Group, (Reuters Code: SORN.MI), a global medical device company 
      and a leader in the treatment of cardiovascular diseases, announced 
      ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Sorin-Group-Announces-FDA-Approval-and-Commercial-Launch-of-Complete-Portfolio-of-Implantable-Heart-Device-Leads-1856711</guid></item><item><title>SORIN GROUP ANNOUNCES PUBLICATION OF FULL CLEAR STUDY RESULTS IN PEER REVIEWED CARDIOLOGY JOURNAL</title><link>http://www.finanzen.net/nachricht/SORIN-GROUP-ANNOUNCES-PUBLICATION-OF-FULL-CLEAR-STUDY-RESULTS-IN-PEER-REVIEWED-CARDIOLOGY-JOURNAL-1853748</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwalignc {text-align: center}
--&gt;
&lt;/style&gt;

			
      Sorin Group, (Reuters Code: SORN.MI), a global medical device company 
      and a leader in the treatment of cardiovascular diseases, announced 
      today at  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/SORIN-GROUP-ANNOUNCES-PUBLICATION-OF-FULL-CLEAR-STUDY-RESULTS-IN-PEER-REVIEWED-CARDIOLOGY-JOURNAL-1853748</guid></item><item><title>Sorin Group Announces FDA Approval and Commercial Launch of PARADYM(TM) RF ICDs and CRT-D Implantable Heart Devices</title><link>http://www.finanzen.net/nachricht/Sorin-Group-Announces-FDA-Approval-and-Commercial-Launch-of-PARADYM-TM-RF-ICDs-and-CRT-D-Implantable-Heart-Devices-1851382</link><description>
			
      Sorin Group, (Reuters Code: SORN.MI), a global medical device company 
      and a leader in the treatment of cardiovascular diseases, announced 
      today at Heart Rhythm 2012, the Heart Rhythm Society’s 33&lt;sup&gt;rd&lt;/sup&gt; 
      Annual  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Sorin-Group-Announces-FDA-Approval-and-Commercial-Launch-of-PARADYM-TM-RF-ICDs-and-CRT-D-Implantable-Heart-Devices-1851382</guid></item><item><title>Sorin Group: Solid Start to 2012: Underlying Revenue Growth of 2.8%* in the First Quarter</title><link>http://www.finanzen.net/nachricht/Sorin-Group-Solid-Start-to-2012-Underlying-Revenue-Growth-of-2-8-in-the-First-Quarter-1813159</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwalignc {text-align: center}
.bwalignl {text-align: left}
.bwlistitemmargb {margin-bottom: 10.0px}
.bwnowrap {white-space: nowrap}
.bwpadl0 {padding-left: 0.0px}
.bwpadr0 {padding-right: 0.0px}
.bwsinglebottom {border-bottom:  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Sorin-Group-Solid-Start-to-2012-Underlying-Revenue-Growth-of-2-8-in-the-First-Quarter-1813159</guid></item><item><title>Sorin Group : Final Results for 2011 Confirm Preliminary Figures Published on February 9, 2012</title><link>http://www.finanzen.net/nachricht/Sorin-Group-Final-Results-for-2011-Confirm-Preliminary-Figures-Published-on-February-9-2012-1733973</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwalignc {text-align: center}
.bwalignl {text-align: left}
.bwlistitemmargb {margin-bottom: 10.0px}
.bwnowrap {white-space: nowrap}
.bwpadl0 {padding-left: 0.0px}
.bwpadr0 {padding-right: 0.0px}
.bwsinglebottom {border-bottom:  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Sorin-Group-Final-Results-for-2011-Confirm-Preliminary-Figures-Published-on-February-9-2012-1733973</guid></item><item><title>Sorin Group Announces First Implant in U.S. Study of Stentless Pericardial Aortic Valve</title><link>http://www.finanzen.net/nachricht/Sorin-Group-Announces-First-Implant-in-U-S-Study-of-Stentless-Pericardial-Aortic-Valve-1669186</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwalignc {text-align: center}
--&gt;
&lt;/style&gt;

			
      Sorin Group, (MIL:SRN)(Reuters Code: SORN.MI), a global medical company 
      and a leader in the treatment of cardiovascular diseases, today 
      announced initiation  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Sorin-Group-Announces-First-Implant-in-U-S-Study-of-Stentless-Pericardial-Aortic-Valve-1669186</guid></item><item><title>Sorin: Preliminary Results for 2011: Net Profit Increases by 48.5%</title><link>http://www.finanzen.net/nachricht/Sorin-Preliminary-Results-for-2011-Net-Profit-Increases-by-48-5-1636465</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwalignc {text-align: center}
.bwalignl {text-align: left}
.bwlistitemmargb {margin-bottom: 10.0px}
.bwnowrap {white-space: nowrap}
.bwpadl0 {padding-left: 0.0px}
.bwpadr0 {padding-right: 0.0px}
.bwsinglebottom {border-bottom:  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Sorin-Preliminary-Results-for-2011-Net-Profit-Increases-by-48-5-1636465</guid></item><item><title>Sorin Group Launches a New Complete Portfolio of Pacing, Defibrillation and Left Ventricular Leads</title><link>http://www.finanzen.net/nachricht/Sorin-Group-Launches-a-New-Complete-Portfolio-of-Pacing-Defibrillation-and-Left-Ventricular-Leads-1605114</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwalignc {text-align: center}
.bwlistitemmargb {margin-bottom: 10.0px}
--&gt;
&lt;/style&gt;

			&lt;!-- sh_cad_1 --&gt;
      Sorin Group, (MIL:SRN) (Reuters Code: SORN.MI), a global medical company 
      and a leader in the treatment  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Sorin-Group-Launches-a-New-Complete-Portfolio-of-Pacing-Defibrillation-and-Left-Ventricular-Leads-1605114</guid></item><item><title>Sorin Group Opens New International Training Center for Healthcare Professionals</title><link>http://www.finanzen.net/nachricht/Sorin-Group-Opens-New-International-Training-Center-for-Healthcare-Professionals-1597339</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwalignc {text-align: center}
--&gt;
&lt;/style&gt;

			
      Sorin Group, (MIL:SRN) (Reuters Code: SORN.MI), a global medical company 
      and a leader in the treatment of cardiovascular diseases, announced 
      today  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Sorin-Group-Opens-New-International-Training-Center-for-Healthcare-Professionals-1597339</guid></item></channel></rss>

